메뉴 건너뛰기




Volumn 15, Issue 1, 2000, Pages 44-50

Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: Relationship with clinicopathologic parameters and prognostic significance

Author keywords

Colorectal cancer; Plasminogen activator; Prognosis; tPA

Indexed keywords

BIOCHEMICAL MARKER; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034075348     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080001500108     Document Type: Article
Times cited : (13)

References (35)
  • 1
    • 0030757461 scopus 로고    scopus 로고
    • Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990
    • Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-107.
    • (1997) Eur J Cancer , vol.33 , pp. 1075-1107
    • Black, R.J.1    Bray, F.2    Ferlay, J.3    Parkin, D.M.4
  • 2
    • 0026782113 scopus 로고
    • Colon cancer overview
    • Greenwald P. Colon cancer overview. Cancer 1992; 70: 1206-15.
    • (1992) Cancer , vol.70 , pp. 1206-1215
    • Greenwald, P.1
  • 3
    • 0032414932 scopus 로고    scopus 로고
    • Survival of colorectal cancer patients in Europe during the period 1978-1989
    • Gatta G, Faivre J, Capocaccia R, Ponz de Leon M, the EUROCARE Working Group. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998; 34: 2176-83.
    • (1998) Eur J Cancer , vol.34 , pp. 2176-2183
    • Gatta, G.1    Faivre, J.2    Capocaccia, R.3    Ponz De Leon, M.4
  • 4
    • 0020358908 scopus 로고
    • Role of collagenases in tumor cell invasion, tissue degradation, and cancer
    • Liotta LA, Thorgeirsson UP, Garbisa S. Role of collagenases in tumor cell invasion, tissue degradation, and cancer. Cancer Metastasis Rev 1982; 1: 277-97.
    • (1982) Cancer Metastasis Rev , vol.1 , pp. 277-297
    • Liotta, L.A.1    Thorgeirsson, U.P.2    Garbisa, S.3
  • 5
    • 0027535914 scopus 로고
    • Biology and biochemistry of proteinases in tumor invasion
    • Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-95.
    • (1993) Physiol Rev , vol.73 , pp. 161-195
    • Mignatti, P.1    Rifkin, D.B.2
  • 8
    • 0025983254 scopus 로고
    • Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis
    • Sier CFM, Verspaget HW, Griffioen G, et al. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis. Gastroenterology 1991; 101: 1522-8.
    • (1991) Gastroenterology , vol.101 , pp. 1522-1528
    • Sier, C.F.M.1    Verspaget, H.W.2    Griffioen, G.3
  • 10
    • 0026655384 scopus 로고
    • Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues
    • Nakamura M, Konno H, Tanaka T, et al. Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. Thromb Res 1992; 65: 709-19.
    • (1992) Thromb Res , vol.65 , pp. 709-719
    • Nakamura, M.1    Konno, H.2    Tanaka, T.3
  • 11
    • 0028363578 scopus 로고
    • Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression
    • De Vries TJ, Quax PHA, Denijn M, et al. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 1994; 144: 70-81.
    • (1994) Am J Pathol , vol.144 , pp. 70-81
    • De Vries, T.J.1    Quax, P.H.A.2    Denijn, M.3
  • 12
    • 0025127815 scopus 로고
    • Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
    • Jänicke F, Schmitt M, Hafter R, et al. Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis 1990; 4: 69-78.
    • (1990) Fibrinolysis , vol.4 , pp. 69-78
    • Jänicke, F.1    Schmitt, M.2    Hafter, R.3
  • 13
    • 0026440080 scopus 로고
    • Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients
    • Foekens JA, Schmitt M, van Putten WLJ, et al. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 1992; 52: 6101-5.
    • (1992) Cancer Res , vol.52 , pp. 6101-6105
    • Foekens, J.A.1    Schmitt, M.2    Van Putten, W.L.J.3
  • 14
  • 15
    • 0027223048 scopus 로고
    • High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
    • Gröndahl-Hansen J, Christensen IJ, Rosenquist C, et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993; 53: 2513-21.
    • (1993) Cancer Res , vol.53 , pp. 2513-2521
    • Gröndahl-Hansen, J.1    Christensen, I.J.2    Rosenquist, C.3
  • 16
    • 0032953135 scopus 로고    scopus 로고
    • Prognostic value of tissue-type plasminogen activator (tPA) and its complex with type-1 inhibitor (PAI-1) in breast cancer
    • De Witte JH, Sweep CGJ, Klijn JGM, et al. Prognostic value of tissue-type plasminogen activator (tPA) and its complex with type-1 inhibitor (PAI-1) in breast cancer. Br J Cancer 1999; 80: 286-94.
    • (1999) Br J Cancer , vol.80 , pp. 286-294
    • De Witte, J.H.1    Sweep, C.G.J.2    Klijn, J.G.M.3
  • 17
    • 0033109360 scopus 로고    scopus 로고
    • Cathepsin D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: An immunohistochemical study of prognostic value and relations to tenascin-C and other factors
    • Jahkola T, Toivonen T, von Smitten K, et al. Cathepsin D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors. Br J Cancer 1999; 80: 167-74.
    • (1999) Br J Cancer , vol.80 , pp. 167-174
    • Jahkola, T.1    Toivonen, T.2    Von Smitten, K.3
  • 18
    • 0028070859 scopus 로고
    • Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue
    • Pedersen H, Brunner N, Francis D, et al. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 1994; 54: 4671-5.
    • (1994) Cancer Res , vol.54 , pp. 4671-4675
    • Pedersen, H.1    Brunner, N.2    Francis, D.3
  • 19
    • 0028321634 scopus 로고
    • Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer
    • Nekarda H, Schmitt M, Ulm K, et al. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 1994; 54: 2900-7.
    • (1994) Cancer Res , vol.54 , pp. 2900-2907
    • Nekarda, H.1    Schmitt, M.2    Ulm, K.3
  • 20
    • 0026603255 scopus 로고
    • The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer
    • Hasui Y, Marutsuka K, Suzumiya J, Kitada S, Osada Y, Sumiyoshi A. The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer. Int J Cancer 1992; 50: 871-3.
    • (1992) Int J Cancer , vol.50 , pp. 871-873
    • Hasui, Y.1    Marutsuka, K.2    Suzumiya, J.3    Kitada, S.4    Osada, Y.5    Sumiyoshi, A.6
  • 21
    • 0022473105 scopus 로고
    • Tissue-type plasminogen activator in breast cancer: Relationship with estradiol and progesterone receptors
    • Duffy MJ, O'Grady P, Simon J, Rose M, Lijnen HR. Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors. J Natl Cancer Inst 1986; 77: 621-3.
    • (1986) J Natl Cancer Inst , vol.77 , pp. 621-623
    • Duffy, M.J.1    O'Grady, P.2    Simon, J.3    Rose, M.4    Lijnen, H.R.5
  • 22
    • 0025995880 scopus 로고
    • Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type-1 inhibitor in breast cancer
    • Jänicke F, Schmitt M, Graeff H. Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type-1 inhibitor in breast cancer. Semin Thromb Hemost 1991; 17: 303-12.
    • (1991) Semin Thromb Hemost , vol.17 , pp. 303-312
    • Jänicke, F.1    Schmitt, M.2    Graeff, H.3
  • 23
    • 0023244770 scopus 로고
    • Plasminogen activators and tumor development in the human colon: Activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas
    • De Bruin PAF, Griffioen G, Verspaget HW, Verheijen JH, Lamers CBHW. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas. Cancer Res 1987; 46: 4654-7.
    • (1987) Cancer Res , vol.46 , pp. 4654-4657
    • De Bruin, P.A.F.1    Griffioen, G.2    Verspaget, H.W.3    Verheijen, J.H.4    Lamers, C.B.H.W.5
  • 24
  • 25
    • 0027935805 scopus 로고
    • Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
    • Ganesh S, Sier CFM, Griffioen G, et al. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 1994; 54: 4065-75.
    • (1994) Cancer Res , vol.54 , pp. 4065-4075
    • Ganesh, S.1    Sier, C.F.M.2    Griffioen, G.3
  • 26
    • 0027968819 scopus 로고
    • Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer
    • Mulcahy HE, Duffy MJ, Gibbons D, et al. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 1994; 344: 583-4.
    • (1994) Lancet , vol.344 , pp. 583-584
    • Mulcahy, H.E.1    Duffy, M.J.2    Gibbons, D.3
  • 27
    • 8244225180 scopus 로고    scopus 로고
    • Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer
    • Ganesh S, Sier CFM, Heerding MM, et al. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. Br J Cancer 1997; 75: 1793-801.
    • (1997) Br J Cancer , vol.75 , pp. 1793-1801
    • Ganesh, S.1    Sier, C.F.M.2    Heerding, M.M.3
  • 28
    • 0001554828 scopus 로고
    • The classification of cancer of the rectum
    • Dukes CE. The classification of cancer of the rectum. J Path Pract 1932; 35: 323-32.
    • (1932) J Path Pract , vol.35 , pp. 323-332
    • Dukes, C.E.1
  • 29
    • 0001646225 scopus 로고
    • The grading of carcinoma
    • Broders AC. The grading of carcinoma. Minn Med 1925; 8: 726.
    • (1925) Minn Med , vol.8 , pp. 726
    • Broders, A.C.1
  • 32
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding
    • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
    • (1976) Anal Biochem , vol.72 , pp. 248-254
    • Bradford, M.M.1
  • 34
    • 0025968060 scopus 로고
    • Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse
    • Ossowski L, Russo-Payne H, Wilson EL. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res 1991; 51: 274-81.
    • (1991) Cancer Res , vol.51 , pp. 274-281
    • Ossowski, L.1    Russo-Payne, H.2    Wilson, E.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.